Alteplase
1 NDC across 1 manufacturer|0 Generic,1 Brand
Alteplase is used to treat arterial occlusive diseases, intracranial embolism and thrombosis, myocardial infarction, pulmonary embolism and stroke, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Alteplase is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $186.38 to $186.38 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$186.38 – $186.38
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ALTEPLASE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CATHFLO ACTIVASE 2 MG VIAL | $186.3796 per EA | — |
Frequently Asked Questions
What is Alteplase used to treat?
Alteplase is used to treat arterial occlusive diseases, intracranial embolism and thrombosis, myocardial infarction, pulmonary embolism and stroke, per the National Library of Medicine's MED-RT classification.
How many Alteplase products are on the market?
The Alteplase drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Alteplase?
NADAC reference prices for Alteplase range from $186.3796 to $186.3796 per EA.
Which manufacturers make Alteplase?
1 manufacturer lists Alteplase in NADAC. Ranked by number of NDCs, the largest are Genentech, Inc. (1).